Understanding the Potential Drug Target Poteb3 (G102724631)

Target Name: POTEB3

NCBI ID: G102724631

POTEB3

Understanding the Potential Drug Target Poteb3

Poteb3, also known as POTEN1, is a member of the B-like Poteb family and belongs to the superfamily of ANKYRIN DOMAIN FAMILES. Poteb3 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its function is not well understood, but it is believed to play a role in signaling and metabolism.

Poteb3 is a 21-kDa protein that is expressed in the brain, heart, and kidneys. It is a member of the B-like Poteb family and belongs to the superfamily of ANKYRIN DOMAIN FAMILIES. Poteb3 is a protein that is involved in various signaling pathways, including the sonic hedgehog pathway and the NF-kappa pathway.

Poteb3 has been shown to play a role in the development and progression of various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases. Its function is also being investigated as a potential drug target.

Drug Targeting

Poteb3 is a protein that has been shown to be involved in various signaling pathways, including the sonic hedgehog pathway and the NF-kappa pathway. As a result, Poteb3 is a potential drug target for various diseases.

One of the potential drug targets for Poteb3 is the sonic hedgehog pathway. The sonic hedgehog pathway is a signaling pathway that is involved in the development and progression of various diseases, including cancer. Poteb3 has been shown to be involved in this pathway and has been shown to play a role in the development of various diseases.

Another potential drug target for Poteb3 is the NF-kappa pathway. The NF-kappa pathway is a signaling pathway that is involved in the development and regulation of various tissues, including muscles, bones, and organs. Poteb3 has been shown to be involved in this pathway and has been shown to play a role in the development of various diseases.

Biomarker

Poteb3 is also being investigated as a potential biomarker for various diseases. Its function as a protein involved in signaling pathways is being studied as a potential biomarker for the development and progression of various diseases.

Conclusion

Poteb3 is a protein that is expressed in various tissues of the body and is involved in various signaling pathways, including the sonic hedgehog pathway and the NF-kappa pathway. Its function is not well understood, but it is believed to play a role in signaling and metabolism. Poteb3 is a potential drug target for various diseases, including cancer, neurodegenerative diseases, and cardiovascular diseases, and is also being investigated as a potential biomarker for the development and progression of these diseases. Further research is needed to fully understand its function and to develop effective treatments.

Protein Name: POTE Ankyrin Domain Family Member B3

The "POTEB3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about POTEB3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets